Clinical Trials on Graft Occlusion, Vascular in Japan

Total 1115 results

Medtronic Endovascular

Completed

MDT-2113 Drug-Eluting Balloon vs. Standard PTA for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery and/or Proximal Popliteal Artery (MDT-2113 SFA)

Popliteal Artery Stenosis | Popliteal Artery Occlusion | Femoral Artery Occlusion | Femoral Artery Stenosis

Japan
Tokyo Medical University

Unknown

Development of Intravitreal Ranibizumab by Determining the Pathogenesis of Macular Edema With Retinal Vein Occlusion

Central Retinal Vein Occlusion | Macular Edema | Branch Retinal Vein Occlusion

Japan
Nagoya City University
Novartis

Completed

Evaluation of the Usefulness of a PRN Regimen Using Ranibizumab for Macular Edema Due to Branch Retinal Vein Occlusion

Branch Retinal Vein Occlusion

Japan
Mie University

Unknown

Predictive Factors of Ranibizumab Treatment in Macular Edema With CRVO (CRVO)

Central Retinal Vein Occlusion

Japan
Santen Pharmaceutical Co., Ltd.

Completed

Efficacy and Safety of Betamethasone Microsphere in Patients With Macular Edema Following Branch Retinal Vein Occlusion (HIKARI)

Macular Edema Following Branch Retinal Vein Occlusion

Japan, Korea, Republic of
Astellas Pharma Inc

Completed

A Study to Assess Efficacy, Safety and Pharmacokinetics of a Tacrolimus New Oral Formulation (MR4) in BMT Recipients

Bone Marrow Transplantation | Graft Versus Host Disease | Graft-Versus-Host Disease | Graft-Vs-Host Disease

Japan
Astellas Pharma Inc

Completed

A Study to Assess the Safety and Efficacy of a Tacrolimus New Oral Formulation (MR4) in BMT Patients-Extension-

Bone Marrow Transplantation | Graft Versus Host Disease | Graft-Versus-Host Disease | Graft-Vs-Host Disease

Japan
Abbott Medical Devices

Completed

XIENCE PRIME Japan Post-Marketing Surveillance (PMS)

Myocardial Ischemia | Coronary Artery Disease | Coronary Occlusion | Coronary Artery Stenosis | Angina

Japan
Kyoto University, Graduate School of Medicine
Novartis

Unknown

Ranibizumab Treatment for Retinal Vein Occlusion

Macular Edema Due to BRVO/CRVO

Japan
Fukushima Medical University

Unknown

Retinal Sensitivity in BRVO After Anti-VEGF Therapy

Branch Retinal Vein Occlusion

Japan
Sanwa Kagaku Kenkyusho Co., Ltd.

Completed

A Study of the Safety and Efficacy of a New Treatment for Macular Edema Resulting From Branch Retinal Vein Occlusion

Macular Degeneration | Macular Edema | Branch Retinal Vein Occlusion

Japan
Janssen Pharmaceutical K.K.

Completed

A Study of the Bruton's Tyrosine Kinase (BTK) Inhibitor Ibrutinib in Participants With Steroid Dependent/Refractory Chronic Graft Versus Host Disease (cGVHD)

Graft vs Host Disease

Japan
W.L.Gore & Associates

Completed

GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study

Vascular Stent-Graft Stenosis

Japan
Johnson & Johnson K.K. Medical Company

Completed

A Clinical Investigation of SM-01 Stenting Versus PTA for the Treatment of Superficial Femoral Artery Disease

Peripheral Vascular Diseases

Japan
GlaxoSmithKline

Completed

Phase I Study of SB-480848(Darapladib) -Repeat Dose Study in Healthy Japanese Male Subjects-

Atherosclerosis

Japan
W.L.Gore & Associates

Completed

GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03)

Peripheral Arterial Disease

Japan
Cook Group Incorporated

Completed

Zilver Flex Post-Market Study in Japan

Peripheral Arterial Disease (PAD)

Japan
Sanofi

Completed

Safety Evaluation of Clopidogrel Sulfate in Patients With Peripheral Arterial Disease

Peripheral Arterial Disease (PAD)

Japan
Aichi Gakuin University

Unknown

Impact of Sarpogrelate in the Function of Endothelial Progenitor Cells

Atherosclerosis

Japan
Shinjo Ophthalmologic Institute

Completed

Vitrectomy for Branch Retinal Vein Occlusion

Vitrectomy

Japan
Abbott Medical Devices

Completed

XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for Japan

Myocardial Ischemia | Coronary Artery Disease | Coronary Disease | Stent Thrombosis | Coronary Restenosis | Chronic Coronary Occlusion | Vascular Disease | Coronary Artery Stenosis | Angina

Japan
Kurume University

Completed

Effects of Chronic Smoking on Circulating Endothelial and Platelet-derived Microparticle

Atherosclerosis

Japan
Medtronic Vascular

Completed

RESOLUTE Japan SVS: The Clinical Evaluation of the MDT-4107 DES in the Treatment of De Novo Lesions in Small Diameter Native Coronary Arteries (RJ-SVS)

Myocardial Ischemia | Cardiovascular Diseases | Coronary Artery Disease | Arterial Occlusive Diseases

Japan
Bayer
Regeneron Pharmaceuticals

Completed

Prospective, Non-interventional, Multi-center Post-authorization Safety Study of Eylea for Central Retinal Vein Occlusion (CRVO) (JPMS-CRVO)

Retinal Vein Occlusion

Japan
Novo Nordisk A/S

Completed

A Research Study Looking at How the Medicine NNC0385-0434 Works in the Body of Healthy Japanese Men

Healthy Volunteers | Atherosclerotic Cardiovascular Disease

Japan
GlaxoSmithKline

Completed

A Phase II Clinical Study of SB-480848 in Dyslipidemic Patients

Atherosclerosis

Japan
Medtronic Endovascular

Completed

TurboHawk™ Japan Trial in Patients With PAD

Peripheral Arterial Disease

Japan
Kurume University

Completed

Detection of Plaque Inflammation by Positron Emission Tomography (PET)-Effects of Simvastatin on Plaque Inflammation

Atherosclerosis

Japan
Translational Research Center for Medical Innovation...
Institute of Biomedical Research and Innovation, Kobe, Hyogo, Japan; Kobe City...

Completed

Stem Cell Study for Patients With Leg Ulcer/Gangrene

Ischemia | Ulcer | Peripheral Vascular Diseases | Gangrene | Leg Pain

Japan
Novartis Pharmaceuticals

Completed

Study to Show a Superior Benefit in Terms of Reduction of Ranibizumab Injections in Patients Receiving Ranibizumab Plus Laser Photocoagulation Combination Therapy Without Loss of Efficacy and Safety (ZIPANGU)

Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)

Japan
Massachusetts General Hospital
Tsuchiura Kyodo General Hospital

Recruiting

Massachusetts General Hospital and Tsuchiura Kyodo General Hospital Coronary Imaging Collaboration

Atherosclerosis

United States, Japan
Abbott Medical Devices

Completed

XIENCE PRIME SV Everolimus Eluting Coronary Stent Japan Post Marketing Surveillance (XIENCE PRIME SV Japan PMS)

Myocardial Ischemia | Coronary Artery Disease | Angina Pectoris | Ischemic Heart Disease | Coronary Artery Occlusion

Japan
Novartis Pharmaceuticals

Completed

Study of Pharmacokinetics, Activity and Safety of Ruxolitinib in Pediatric Patients With Grade II-IV Acute Graft vs. Host Disease

Acute Graft Versus Host Disease

Belgium, Japan, Spain, France, Korea, Republic of, Canada, Italy, Denmark
Incyte Corporation

Completed

Safety of Itacitinib in Combination With Corticosteroids for Treatment of Steroid-Naive Acute Graft-Versus-Host Disease in Japanese Subjects

Acute Graft-versus-host Disease

Japan
Kyushu University
Japan Agency for Medical Research and Development; Ministry of Health, Labour...

Active, not recruiting

Randomized Phase IIb Trial of DVC1-0101

Peripheral Arterial Disease | Intermittent Claudication

Japan
Kenichiro Yamagata

Completed

Ultrasound-guided Femoral Vein Accessibility, Safety and Time for Atrial Fibrillation Treatment (ULTRA-FAST)

Atrial Fibrillation | Peripheral Vascular Disease | Vascular Access Complications

Czechia, Japan
Kyoto University, Graduate School of Medicine

Completed

ShorT and OPtimal Duration of Dual AntiPlatelet Therapy-2 Study (STOPDAPT-2)

Coronary Artery Disease

Japan
Kobe University

Unknown

Multicenter Comparison of Early and Late Vascular Responses to Everolimus-eluting Cobalt-CHromium Stent

Coronary Artery Disease

Japan
Fujita Health University

Unknown

Comparison Between OFDI and IVUS in PCI Guidance for Biolimus A9 Eluting Stent Implantation (MISTIC-1)

Coronary Artery Disease

Japan
Teikyo University

Unknown

3-Month Discontinuation of Dual Antiplatelet Therapy After Ultimaster Sirolimus-Eluting Stent Implantation (MODEL U-SES)

Coronary Artery Disease

Japan
Takeshi Morimoto

Completed

Evaluation of Routine Follow-up Coronary Angiography After Percutaneous Coronary Intervention Trial (ReACT)

Coronary Artery Disease

Japan
Takeshi Morimoto

Completed

Short and Optimal Duration of Dual Antiplatelet Therapy Study (STOPDAPT)

Coronary Artery Disease

Japan
Takeshi Morimoto

Completed

Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting Stent Trial (RESET)

Coronary Artery Disease

Japan
Kumamoto University

Completed

Impaired Peripheral Endothelial Function and In-stent Restenosis

Coronary Artery Disease

Japan
Ono Pharmaceutical Co. Ltd

Completed

Study of ONO-1101 in Patients Scheduled for Coronary Angiography

Coronary Artery Disease

Japan
Takeshi Morimoto

Completed

Clopidogrel High Dose Evaluation for the Patient With Coronary Artery Disease in Japan (CHOICE)

Coronary Artery Disease

Japan
Takeshi Morimoto

Completed

NOBORI Biolimus-Eluting Versus XIENCE/PROMUS Everolimus-eluting Stent Trial (NEXT)

Coronary Artery Disease

Japan
Okayama University

Completed

Relationship Analysis Between Periodontal Disease and Atherosclerosis in Japanese Medical Cooperation Services (RAPA-JMCS)

Atherosclerosis | Periodontal Disease

Japan
Kumamoto University
Japan Heart Foundation; The 4C trial bureau

Completed

Candesartan for Prevention of Cardiovascular Events After Cypher or Taxus Coronary Stenting (4C) Trial

Coronary Artery Disease | Hypertension

Japan
Hyogo College of Medicine

Withdrawn

Assessment of Stent Strut Coverage and Endothelial Function After Drug-Eluting Stents (ASSESS)

Coronary Artery Disease | Atherosclerosis

Japan

Clinical Trials on Graft Occlusion, Vascular in Japan

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations